查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1585722

血糖試紙市場：按技術、分銷管道分類 - 全球預測 2025-2030 年

Blood Glucose Test Strips Market by Technology (Channel Technology, Wicking Technology), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年血糖試紙市值為59.1億美元，預計2024年將達到63.7億美元，複合年成長率為7.86%，預計到2030年將達到100.5億美元。

血糖試紙在糖尿病管理中至關重要，它使個人能夠有效監測自己的血糖值。此市場範圍主要涵蓋醫療保健應用，包括糖尿病患者的個人使用和臨床環境中的使用。由於這些試紙對於糖尿病的診斷和管理至關重要，因此它們具有廣泛的最終用途，從醫院、診所到居家醫療場所。由於生活型態的改變、人口老化和肥胖增加等因素，全世界糖尿病盛行率不斷上升，證明了對血糖試紙的需求。關鍵的成長要素包括技術進步，例如無編碼試紙的開發、健康意識的提高以及政府促進糖尿病治療的措施。此外，在新興市場擴大醫療基礎設施也提供了巨大的成長潛力。然而，市場擴張受到定價壓力、報銷問題和嚴格監管標準等因素的阻礙。此外，與連續血糖監測系統的競爭也是一個問題。創新易於使用、侵入性較小的檢測解決方案的機會比比皆是，以提高患者的依從性並滿足日益成長的個人化醫療需求。公司可以投資開發具有先進分析功能的試紙，並與數位健康平台整合，以進行即時監控和資料分析。與數位健康公司合作提供全面的糖尿病管理解決方案還可以開啟新的收益來源。市場嚴重偏向創新和研究，這表明將人工智慧和物聯網整合到產品中有可能徹底改變疾病管理。透過相關人員的參與了解患者的需求和監管要求對於永續成長至關重要。企業應注重策略夥伴關係和收購，以有效進入新市場，確保創新和成本效率之間的平衡，以保持市場競爭力。

主要市場統計
基準年[2023] 59.1億美元
預測年份 [2024] 63.7億美元
預測年份 [2030] 100.5億美元
複合年成長率（%） 7.86%

市場動態：快速發展的血糖試紙市場的關鍵市場洞察

供需的動態交互作用正在改變血糖試紙市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 隨著糖尿病患者數量的增加，需要有效的方法來檢測血糖值的快速變化
    • 糖尿病預防保健意識
    • 糖尿病用品購買和使用指南
  • 市場限制因素
    • 糖尿病管理成本高
  • 市場機會
    • 線上產品普及
    • 亞洲新興經濟體因糖尿病人口龐大和醫療費用上漲而具有潛力
  • 市場挑戰
    • 血糖試紙準確度不夠

波特五力：駕馭血糖試紙市場的策略工具

波特的五力框架是了解血糖試紙市場競爭格局的關鍵工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解血糖試紙市場的外部影響

外部宏觀環境因素在塑造血糖試紙市場的表現動態中起著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解血糖試紙市場競爭格局

血糖試紙市場的詳細市場佔有率分析可以對供應商的業績進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣血糖試紙市場供應商的績效評估

FPNV定位矩陣是評估血糖試紙市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了血糖試紙市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對血糖試紙市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監管核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 隨著糖尿病患者數量的增加，需要一種有效檢測血糖值快速變化的方法。
      • 糖尿病預防保健意識
      • 糖尿病用品購買和使用指南
    • 抑制因素
      • 糖尿病管理成本高昂
    • 機會
      • 線上產品可用性快速增加
      • 亞洲新興經濟體因糖尿病人口眾多和醫療費用上漲而具有潛力
    • 任務
      • 血糖試紙缺乏準確性
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章血糖試紙市場：依技術分類

  • 通路技術
  • 芯吸技術

第7章血糖試紙市場：依通路

  • 醫院藥房
  • 網路藥房
  • 零售藥房

第8章美洲血糖試紙市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太血糖試紙市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章 血糖檢測試紙市場歐洲、中東和非洲

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • A. Menarini Diagnostics srl
  • AgaMatrix, Inc.
  • B. Braun Medical Ltd
  • Bayer AG
  • BioSensors, Inc.
  • F. Hoffmann-La Roche Ltd
  • GlucoRx Limited
  • i-SENS Inc
  • LifeScan, Inc.
  • National Diagnostic Products Pty Ltd
  • Nipro Diagnostics UK Limited
  • PHC Holdings Corporation
  • Spirit Healthcare
  • TaiDoc Technology Corporation
  • Universal Biosensors Group
Product Code: MRR-437D4595830A

The Blood Glucose Test Strips Market was valued at USD 5.91 billion in 2023, expected to reach USD 6.37 billion in 2024, and is projected to grow at a CAGR of 7.86%, to USD 10.05 billion by 2030.

Blood Glucose Test Strips are pivotal in diabetes management, allowing individuals to monitor their blood sugar levels effectively. The scope of this market primarily encompasses healthcare applications, including personal use by diabetics and clinical settings. These strips are essential for diagnosing and managing diabetes, thus catering to a broad end-use scope ranging from hospitals and clinics to home care environments. The necessity of blood glucose test strips is underscored by the rising prevalence of diabetes globally, driven by factors like lifestyle changes, aging populations, and increasing incidences of obesity. Key growth factors include technological advancements such as the development of no-coding strips, increasing health awareness, and government initiatives promoting diabetes care. Moreover, expanding healthcare infrastructure across emerging markets offers an immense potential for growth. However, market expansion is hindered by factors such as pricing pressures, reimbursement issues, and stringent regulatory standards. Additionally, competition from continuous blood glucose monitoring systems poses a challenge. Opportunities abound in innovating user-friendly and minimally invasive testing solutions to enhance patient compliance and meet the growing demand for personalized medicine. Companies can invest in developing strips with advanced analytics capabilities integrated with digital health platforms for real-time monitoring and data analysis. Collaborations with digital health companies to offer comprehensive diabetes management solutions could also open new revenue streams. The market leans heavily towards innovation and research, suggesting that the integration of AI and IoT in product offerings could revolutionize disease management. Understanding patient needs and regulatory demands by engaging with stakeholders will be crucial for sustained growth. Businesses should focus on strategic partnerships and acquisitions to penetrate new markets effectively, ensuring a balance between innovation and cost-efficiency to maintain competitiveness in this evolving landscape.

KEY MARKET STATISTICS
Base Year [2023] USD 5.91 billion
Estimated Year [2024] USD 6.37 billion
Forecast Year [2030] USD 10.05 billion
CAGR (%) 7.86%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Blood Glucose Test Strips Market

The Blood Glucose Test Strips Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Need an effective way to detect drastic changes in blood glucose for increasing diabetes cases
    • Awareness about diabetes preventive care
    • Guidelines for buying and using diabetes supplies
  • Market Restraints
    • High diabetes management costs
  • Market Opportunities
    • Proliferation of online product availability
    • Potential in emerging economies in Asia due to huge diabetic population and increasing health spending
  • Market Challenges
    • Lack of accuracy in blood glucose test strips

Porter's Five Forces: A Strategic Tool for Navigating the Blood Glucose Test Strips Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Blood Glucose Test Strips Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Blood Glucose Test Strips Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Blood Glucose Test Strips Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Blood Glucose Test Strips Market

A detailed market share analysis in the Blood Glucose Test Strips Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Blood Glucose Test Strips Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Blood Glucose Test Strips Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Blood Glucose Test Strips Market

A strategic analysis of the Blood Glucose Test Strips Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Blood Glucose Test Strips Market, highlighting leading vendors and their innovative profiles. These include A. Menarini Diagnostics s.r.l, AgaMatrix, Inc., B. Braun Medical Ltd, Bayer AG, BioSensors, Inc., F. Hoffmann-La Roche Ltd, GlucoRx Limited, i-SENS Inc, LifeScan, Inc., National Diagnostic Products Pty Ltd, Nipro Diagnostics UK Limited, PHC Holdings Corporation, Spirit Healthcare, TaiDoc Technology Corporation, and Universal Biosensors Group.

Market Segmentation & Coverage

This research report categorizes the Blood Glucose Test Strips Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Technology, market is studied across Channel Technology and Wicking Technology.
  • Based on Distribution Channel, market is studied across Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Need an effective way to detect drastic changes in blood glucose for increasing diabetes cases
      • 5.1.1.2. Awareness about diabetes preventive care
      • 5.1.1.3. Guidelines for buying and using diabetes supplies
    • 5.1.2. Restraints
      • 5.1.2.1. High diabetes management costs
    • 5.1.3. Opportunities
      • 5.1.3.1. Proliferation of online product availability
      • 5.1.3.2. Potential in emerging economies in Asia due to huge diabetic population and increasing health spending
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of accuracy in blood glucose test strips
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Blood Glucose Test Strips Market, by Technology

  • 6.1. Introduction
  • 6.2. Channel Technology
  • 6.3. Wicking Technology

7. Blood Glucose Test Strips Market, by Distribution Channel

  • 7.1. Introduction
  • 7.2. Hospital Pharmacies
  • 7.3. Online Pharmacies
  • 7.4. Retail Pharmacies

8. Americas Blood Glucose Test Strips Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Blood Glucose Test Strips Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Blood Glucose Test Strips Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. A. Menarini Diagnostics s.r.l
  • 2. AgaMatrix, Inc.
  • 3. B. Braun Medical Ltd
  • 4. Bayer AG
  • 5. BioSensors, Inc.
  • 6. F. Hoffmann-La Roche Ltd
  • 7. GlucoRx Limited
  • 8. i-SENS Inc
  • 9. LifeScan, Inc.
  • 10. National Diagnostic Products Pty Ltd
  • 11. Nipro Diagnostics UK Limited
  • 12. PHC Holdings Corporation
  • 13. Spirit Healthcare
  • 14. TaiDoc Technology Corporation
  • 15. Universal Biosensors Group

LIST OF FIGURES

  • FIGURE 1. BLOOD GLUCOSE TEST STRIPS MARKET RESEARCH PROCESS
  • FIGURE 2. BLOOD GLUCOSE TEST STRIPS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. BLOOD GLUCOSE TEST STRIPS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. BLOOD GLUCOSE TEST STRIPS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BLOOD GLUCOSE TEST STRIPS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BLOOD GLUCOSE TEST STRIPS MARKET DYNAMICS
  • TABLE 7. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY CHANNEL TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY WICKING TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 17. ARGENTINA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 18. ARGENTINA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 19. BRAZIL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 20. BRAZIL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 21. CANADA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 22. CANADA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 23. MEXICO BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 24. MEXICO BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 25. UNITED STATES BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 28. ASIA-PACIFIC BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 31. AUSTRALIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 32. AUSTRALIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 33. CHINA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 34. CHINA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 35. INDIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 36. INDIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 37. INDONESIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 38. INDONESIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 39. JAPAN BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 40. JAPAN BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 41. MALAYSIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 42. MALAYSIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 43. PHILIPPINES BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 44. PHILIPPINES BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 45. SINGAPORE BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 46. SINGAPORE BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 47. SOUTH KOREA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 48. SOUTH KOREA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 49. TAIWAN BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 50. TAIWAN BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 51. THAILAND BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 52. THAILAND BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 53. VIETNAM BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 54. VIETNAM BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 58. DENMARK BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 59. DENMARK BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 60. EGYPT BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 61. EGYPT BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 62. FINLAND BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 63. FINLAND BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 64. FRANCE BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 65. FRANCE BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 66. GERMANY BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 67. GERMANY BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 68. ISRAEL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 69. ISRAEL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 70. ITALY BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 71. ITALY BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 72. NETHERLANDS BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 73. NETHERLANDS BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 74. NIGERIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 75. NIGERIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 76. NORWAY BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 77. NORWAY BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 78. POLAND BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 79. POLAND BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 80. QATAR BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 81. QATAR BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 82. RUSSIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 83. RUSSIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 84. SAUDI ARABIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 85. SAUDI ARABIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH AFRICA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH AFRICA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 88. SPAIN BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 89. SPAIN BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 90. SWEDEN BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 91. SWEDEN BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 92. SWITZERLAND BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 93. SWITZERLAND BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 94. TURKEY BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 95. TURKEY BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED ARAB EMIRATES BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED ARAB EMIRATES BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED KINGDOM BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED KINGDOM BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 100. BLOOD GLUCOSE TEST STRIPS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 101. BLOOD GLUCOSE TEST STRIPS MARKET, FPNV POSITIONING MATRIX, 2023